NCT07817043

Brief Summary

The goal of this study is to simulate turn-around times of blood cultures from blood culture collection to final communication of the result. The main objective is to develop a web-based tool that is able to simulate heterogeneous laboratory settings and to analyse the impact of infrastructure and opening hours on blood culture turn-around times.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
24mo left

Started Oct 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 8, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 14, 2026

Completed
17 days until next milestone

Study Start

First participant enrolled

October 1, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2028

Last Updated

September 14, 2026

Status Verified

September 1, 2026

Enrollment Period

1 year

First QC Date

September 8, 2026

Last Update Submit

September 8, 2026

Conditions

SepsisSeptic ShockBloodstream InfectionBacteremiaBacterial Infections

Keywords

Sepsisblood culturesopening hoursinfrastructuremicrobiologylaboratorysimulation

Outcome Measures

Primary Outcomes (1)

  • Turn-around time

    4 weeks for the conduction of the simulation

Interventions

laboratory infrastructureDIAGNOSTIC_TEST

will follow

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

microbiological laboratories

microbiological laboratories conducting blood culture analysis

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

University Medicine Greifswald

Greifswald, Germany

Location

MeSH Terms

Conditions

SepsisBacterial InfectionsShock, SepticBacteremia

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsBacterial Infections and MycosesShock

Central Study Contacts

Christian S Scheer, MD

CONTACT

christian.scheer@med.uni-greifswald.de

Evgeny A Idelevich, MD, Prof.

CONTACT

Evgeny.Idelevich@med.uni-greifswald.de

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. med. Christian S. Scheer

Study Record Dates

First Submitted

September 8, 2026

First Posted

September 14, 2026

Study Start

October 1, 2026

Primary Completion (Estimated)

October 1, 2027

Study Completion (Estimated)

October 1, 2028

Last Updated

September 14, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Locations

DE(1)